Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Lactating Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, J. GIELE-ESHUIS, S. SIISKONEN, D. BAUD, M. STURKENBOOM, A. PANCHAUD and G. TRIFIRÒ
Aten Primaria.2022 Aug; 54(9):102437.doi:Epub 2022 Aug 11. Spanish.PMID:

• Ans: 01/11/2024
• FI: 2.4

Interim Results from the VAC4EU Post-Authorization Safety Study (PASS) Among Recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) Vaccine in Europe

D. WEIBEL, C. DE LUISE, A. ROYO, O. RYAN, T. VAZ, J. AGUADO, J. MARSAL, X. MARTINEZ, R. WEINRIB, N. YEFIMENKO, E. PALÀ, B. POBLADOR-PLOU, A. GIMENO-MIGUEL, A. SANTOS-MEJÍAS, E. MARCONI, E. BARBIERI, L. STONA, T. LYSEN, D. ROY, G. HYERACI, A. GIRARDI, A. LUPATTELLI, A. DESALEGN, F. VILLALOBOS, C. BISSACCO, K. KENDRICK, R. GARG, H. RUBINO, M. STURKENBOOM and A. ARANA
Aten Primaria.2022 Aug; 54(9):102437.doi:Epub 2022 Aug 11. Spanish.PMID:

• Ans: 01/11/2024
• FI: 2.4

Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Pregnant Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, S. SIISKONEN, D. BAUD, J. GIELE-ESHUIS, M. STURKENBOOM, G. TRIFIRÒ and A. PANCHAUD
Aten Primaria.2022 Aug; 54(9):102437.doi:Epub 2022 Aug 11. Spanish.PMID:

• Ans: 01/11/2024
• FI: 2.4

Impact of Data Source Diversity on the Distribution of Key Variables in Pregnancy Cohorts Based on the ConcePTION Pregnancy Algorithm Leveraging a Random Forest Imputation Model

A. GIRARDI, G. LIMONCELLA, G. HYERACI, G. ROBERTO, C. BARTOLINI, O. PAOLETTI, D. MESSINA, F. VILLALOBOS, C. BISSACCO, J. VAN DEN BERG, E. HOUBEN, K. SANTACÀ, V. IENTILE, Y. INGRASCIOTTA, G. TRIFIRÒ, V. HOXHAJ, C. DURÁN, J. RIERA-ARNAU, P. GARCIA, M. MARTÍN-PÉREZ, C. HUERTA-ALVAREZ, A. LLORENTE-GARCIA, F. SÁNCHEZ-SÁEZ, G. SANFÉLIX-GIMENO, C. RODRÍGUEZ-BERNAL, R. LASSALLE, J. JOVÉ, M. BERNARD, N. THURIN, S. JORDAN, D. THAYER, H. EVANS, A. COLDEA, M. MANFRINI, M. VAN GELDER, S. HAYATI, T. SCHINK, M. TARI, R. PAJOUHESHNIA, A. AFONSO, M. LE NOAN-LAINÉ, D. MOLGAARD-NIELSEN, M. CUNNINGTON, C. DODD, M. STURKENBOOM, H. NORDENG and R. GINI
Aten Primaria.2022 Aug; 54(9):102437.doi:Epub 2022 Aug 11. Spanish.PMID:

• Ans: 01/11/2024
• FI: 2.4

What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study.

Bellitto C, Luxi N, Ciccimarra F, L'Abbate L, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Marques FB, Morton K, O'Shaughnessy F, Sonderlichová S, Farcas A, Janneke GE, Sturkenboom MC and Trifirò G
Aten Primaria.2022 Aug; 54(9):102437.doi:10.1007/s40264-024-01449-xEpub 2022 Aug 11. Spanish.PMID:38907947

• Ans: 01/10/2024
• FI: 4